| Bioactivity | Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor. Aderamastat can be used for the research of asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis[1]. |
| Name | Aderamastat |
| CAS | 877176-23-3 |
| Formula | C21H18N2O4S |
| Molar Mass | 394.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li, Yuhua, et al. Safe administration of MMP-12 inhibitor. Patent. WO2022261624 A1. |
Aderamastat
CAS: 877176-23-3 F: C21H18N2O4S W: 394.44
Aderamastat (FP-025) is an orally active matrix metalloproteinase 12 (MMP-12) inhibitor. Aderamastat can be used for the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.